View Future GrowthFuchs 過去の業績過去 基準チェック /56Fuchsは、平均年間4.5%の収益成長を遂げていますが、 Chemicals業界の収益は、年間 成長しています。収益は、平均年間3% 5.8%収益成長率で 成長しています。 Fuchsの自己資本利益率は15.2%であり、純利益率は8.9%です。主要情報4.50%収益成長率5.72%EPS成長率Chemicals 業界の成長4.35%収益成長率5.79%株主資本利益率15.23%ネット・マージン8.90%次回の業績アップデート31 Jul 2026最近の業績更新お知らせ • Jan 27+ 1 more updateFuchs SE to Report Q3, 2026 Results on Oct 30, 2026Fuchs SE announced that they will report Q3, 2026 results at 7:00 AM, Central European Standard Time on Oct 30, 2026Reported Earnings • Nov 01Third quarter 2024 earnings releasedThird quarter 2024 results: Revenue: €902.0m (up 3.0% from 3Q 2023). Net income: €80.0m (up 3.9% from 3Q 2023). Profit margin: 8.9% (up from 8.8% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.7% p.a. on average during the next 3 years, compared to a 6.2% decline forecast for the Chemicals industry in the United Kingdom.お知らせ • Oct 16+ 2 more updatesFuchs SE to Report Q1, 2025 Final Results on Apr 30, 2025Fuchs SE announced that they will report Q1, 2025 final results on Apr 30, 2025お知らせ • Aug 29Fuchs SE to Report Fiscal Year 2024 Results on Mar 21, 2025Fuchs SE announced that they will report fiscal year 2024 results on Mar 21, 2025Reported Earnings • Aug 01Second quarter 2024 earnings released: EPS: €0.59 (vs €0.50 in 2Q 2023)Second quarter 2024 results: EPS: €0.59 (up from €0.50 in 2Q 2023). Revenue: €887.0m (flat on 2Q 2023). Net income: €78.0m (up 15% from 2Q 2023). Profit margin: 8.8% (up from 7.7% in 2Q 2023). Revenue is forecast to grow 4.1% p.a. on average during the next 3 years, compared to a 5.8% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.Reported Earnings • May 01First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: €877.0m (down 6.3% from 1Q 2023). Net income: €77.0m (up 5.5% from 1Q 2023). Profit margin: 8.8% (up from 7.8% in 1Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 3.8% p.a. on average during the next 3 years, compared to a 2.7% decline forecast for the Chemicals industry in the United Kingdom.すべての更新を表示Recent updatesお知らせ • Mar 26+ 1 more updateFuchs SE, Annual General Meeting, May 06, 2026Fuchs SE, Annual General Meeting, May 06, 2026, at 10:00 W. Europe Standard Time.お知らせ • Jan 27+ 1 more updateFuchs SE to Report Q3, 2026 Results on Oct 30, 2026Fuchs SE announced that they will report Q3, 2026 results at 7:00 AM, Central European Standard Time on Oct 30, 2026お知らせ • May 02Fuchs SE Reaffirms Earnings Guidance for the Year 2025Fuchs SE reaffirmed earnings guidance for the year 2025. For the year, the company expects sales revenues around EUR 3.7 billion and EBIT around EUR 460 million.お知らせ • Mar 27Fuchs SE, Annual General Meeting, May 07, 2025Fuchs SE, Annual General Meeting, May 07, 2025, at 10:00 W. Europe Standard Time.お知らせ • Mar 23Fuchs SE Proposes Dividend for the Year 2024Fuchs SE proposed to the annual general meeting a dividend increase by 5%, to EUR 1.16 (EUR 1.10) per ordinary share for the year 2024.お知らせ • Mar 22Fuchs SE Provides Earnings Guidance for the Year 2025Fuchs SE provided earnings guidance for the year 2025. For the year, the company expects sales revenues around EUR 3.7 billion and EBIT around EUR 460 million.Reported Earnings • Nov 01Third quarter 2024 earnings releasedThird quarter 2024 results: Revenue: €902.0m (up 3.0% from 3Q 2023). Net income: €80.0m (up 3.9% from 3Q 2023). Profit margin: 8.9% (up from 8.8% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.7% p.a. on average during the next 3 years, compared to a 6.2% decline forecast for the Chemicals industry in the United Kingdom.お知らせ • Oct 16+ 2 more updatesFuchs SE to Report Q1, 2025 Final Results on Apr 30, 2025Fuchs SE announced that they will report Q1, 2025 final results on Apr 30, 2025お知らせ • Sep 13Fuchs SE (XTRA:FPE3) signed a letter of intent to acquire Strub & Co. Ag.Fuchs SE (XTRA:FPE3) signed a letter of intent to acquire Strub & Co. Ag on September 13, 2024. For the period ending December 31, 2023, Strub & Co. Ag reported total revenue of €15 million. The transaction to be completed by the end of 2024.お知らせ • Aug 29Fuchs SE to Report Fiscal Year 2024 Results on Mar 21, 2025Fuchs SE announced that they will report fiscal year 2024 results on Mar 21, 2025Reported Earnings • Aug 01Second quarter 2024 earnings released: EPS: €0.59 (vs €0.50 in 2Q 2023)Second quarter 2024 results: EPS: €0.59 (up from €0.50 in 2Q 2023). Revenue: €887.0m (flat on 2Q 2023). Net income: €78.0m (up 15% from 2Q 2023). Profit margin: 8.8% (up from 7.7% in 2Q 2023). Revenue is forecast to grow 4.1% p.a. on average during the next 3 years, compared to a 5.8% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.Reported Earnings • May 01First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: €877.0m (down 6.3% from 1Q 2023). Net income: €77.0m (up 5.5% from 1Q 2023). Profit margin: 8.8% (up from 7.8% in 1Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 3.8% p.a. on average during the next 3 years, compared to a 2.7% decline forecast for the Chemicals industry in the United Kingdom.お知らせ • Apr 24Fuchs SE (XTRA:FPE3) signed an agreement to acquire Lubricant Consult Gmbh (Gesellschaft FÜR Schmier- Und GrenzflÄChenaktive Stoffe).Fuchs SE (XTRA:FPE3) signed an agreement to acquire Lubricant Consult Gmbh (Gesellschaft FÜR Schmier- Und GrenzflÄChenaktive Stoffe) on April 22, 2024. As of financial year 2023, Lubricant Consult reported a sales revenue of €40 million. The transaction is subject to approval from the cartel authorities and is expected to close in the third quarter of 2024.Reported Earnings • Mar 13Full year 2023 earnings releasedFull year 2023 results: Revenue: €3.54b (up 3.8% from FY 2022). Net income: €282.0m (up 8.9% from FY 2022). Profit margin: 8.0% (up from 7.6% in FY 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.0% p.a. on average during the next 3 years, compared to a 3.9% decline forecast for the Chemicals industry in the United Kingdom.お知らせ • Dec 08Fuchs SE Appoints Dr. Timo Reister as Deputy Chairman of the Executive BoardThe Supervisory Board of FUCHS SE has appointed Dr. Timo Reister (44) as Deputy Chairman of the Executive Board. The appointment will take effect from January 1, 2024 and is part of the company's long-term succession planning. Timo Reister joined FUCHS in 2009 after studying business administration and completing his doctorate and has been a member of the Executive Board based in Mannheim since 2016. After joining the company, he was responsible for the OEM and specialty business in the USA as well as for FUCHS Mexico for almost five years. He then moved to China in 2014, where he headed the Asia-Pacific region as a member of the Group Management Committee. Through these stays, Timo Reister got to know FUCHS' two most important foreign markets on the ground. At present, he is responsible for the two global regions Americas and Asia-Pacific as well as for three global sales divisions: OEM, Automotive Aftermarket and Mining. The responsibilities of the Executive Board remain unchanged by this appointment. In addition to Stefan FUCHS (55) and Dr. Timo Reister (44), the at the end of 2022 newly formed Executive Board team consists of Isabelle Adelt (39), CFO, Dr. Sebastian Heiner (45), CTO, and Dr. Ralph Rheinboldt responsible for the EMEA region (Europe, Africa and Middle East) and the Industry and Specialties divisions.Reported Earnings • Oct 28Third quarter 2023 earnings releasedThird quarter 2023 results: EPS: €0.57. Revenue: €876.0m (down 2.9% from 3Q 2022). Net income: €77.0m (up 10.0% from 3Q 2022). Profit margin: 8.8% (up from 7.8% in 3Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 5.8% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.Buying Opportunity • Oct 26Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 6.2%. The fair value is estimated to be €43.46, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Earnings per share has grown by 8.5%. Revenue is forecast to grow by 3.6% in 2 years. Earnings is forecast to grow by 19% in the next 2 years.お知らせ • Oct 24+ 3 more updatesFuchs SE, Annual General Meeting, May 08, 2024Fuchs SE, Annual General Meeting, May 08, 2024.お知らせ • Sep 12Fuchs SE to Report Fiscal Year 2023 Results on Mar 12, 2024Fuchs SE announced that they will report fiscal year 2023 results Pre-Market on Mar 12, 2024お知らせ • Sep 05Fuchs SE (XTRA:FPE3) acquired the remaining 35% stake in Fuchs lubricants SpA from Comercial Pacific Ltda..Fuchs SE (XTRA:FPE3) acquired the remaining 35% stake in Fuchs lubricants SpA from Comercial Pacific Ltda. on September 1, 2023. Fuchs SE (XTRA:FPE3) completed the acquisition of the remaining 35% stake in Fuchs lubricants SpA from Comercial Pacific Ltda. on September 1, 2023.Reported Earnings • Jul 30Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: €886.0m (up 6.5% from 2Q 2022). Net income: €68.0m (up 12% from 2Q 2022). Profit margin: 7.7% (up from 7.3% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 2.4% p.a. on average during the next 3 years, compared to a 5.9% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.Upcoming Dividend • Apr 27Upcoming dividend of €1.07 per share at 2.9% yieldEligible shareholders must have bought the stock before 04 May 2023. Payment date: 08 May 2023. Payout ratio is a comfortable 57% but the company is paying out more than the cash it is generating. Trailing yield: 2.9%. Lower than top quartile of British dividend payers (5.8%). Higher than average of industry peers (2.3%).Reported Earnings • Mar 09Full year 2022 earnings released: EPS: €1.87 (vs €1.82 in FY 2021)Full year 2022 results: EPS: €1.87 (up from €1.82 in FY 2021). Revenue: €3.41b (up 19% from FY 2021). Net income: €259.0m (up 2.4% from FY 2021). Profit margin: 7.6% (down from 8.8% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.6% p.a. on average during the next 3 years, compared to a 1.5% growth forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 8% per year and the company’s share price has also increased by 8% per year.お知らせ • Jan 02+ 3 more updatesFuchs Petrolub SE, Annual General Meeting, May 03, 2023Fuchs Petrolub SE, Annual General Meeting, May 03, 2023.Reported Earnings • Oct 30Third quarter 2022 earnings releasedThird quarter 2022 results: Revenue: €902.0m (up 26% from 3Q 2021). Net income: €70.0m (up 15% from 3Q 2021). Profit margin: 7.8% (down from 8.5% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 8.6% decline forecast for the Chemicals industry in the United Kingdom.お知らせ • Oct 25Fuchs Petrolub SE to Report Fiscal Year 2022 Results on Mar 08, 2023Fuchs Petrolub SE announced that they will report fiscal year 2022 results on Mar 08, 2023Valuation Update With 7 Day Price Move • Sep 29Investor sentiment improved over the past weekAfter last week's 65% share price gain to €43.87, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 17x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 44% over the past three years.Valuation Update With 7 Day Price Move • Sep 14Investor sentiment improved over the past weekAfter last week's 60% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 18x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 36% over the past three years.Valuation Update With 7 Day Price Move • Aug 30Investor sentiment improved over the past weekAfter last week's 59% share price gain to €43.87, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 18x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 50% over the past three years.Valuation Update With 7 Day Price Move • Aug 15Investor sentiment improved over the past weekAfter last week's 54% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 19x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 49% over the past three years.Reported Earnings • Aug 01Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: €832.0m (up 17% from 2Q 2021). Net income: €61.0m (down 6.2% from 2Q 2021). Profit margin: 7.3% (down from 9.1% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 4.7% compared to a 20% decline forecast for the industry in the United Kingdom.Valuation Update With 7 Day Price Move • Jul 27Investor sentiment improved over the past weekAfter last week's 52% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 19x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 35% over the past three years.Valuation Update With 7 Day Price Move • Jul 12Investor sentiment improved over the past weekAfter last week's 63% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 19x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 31% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €80.44 per share.Valuation Update With 7 Day Price Move • Jun 27Investor sentiment improved over the past weekAfter last week's 75% share price gain to €43.87, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 17x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 32% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €84.69 per share.Valuation Update With 7 Day Price Move • Jun 10Investor sentiment improved over the past weekAfter last week's 50% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 17x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 36% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €74.01 per share.Valuation Update With 7 Day Price Move • May 26Investor sentiment improved over the past weekAfter last week's 59% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 18x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 34% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €77.33 per share.Valuation Update With 7 Day Price Move • May 06Investor sentiment improved over the past weekAfter last week's 46% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 20x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 33% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €77.38 per share.Reported Earnings • May 01First quarter 2022 earnings releasedFirst quarter 2022 results: Revenue: €808.0m (up 16% from 1Q 2021). Net income: €67.0m (down 5.6% from 1Q 2021). Profit margin: 8.3% (down from 10% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 6.9% compared to a 16% decline forecast for the industry in the United Kingdom.Upcoming Dividend • Apr 27Upcoming dividend of €1.03 per shareEligible shareholders must have bought the stock before 04 May 2022. Payment date: 06 May 2022. Payout ratio is a comfortable 57% but the company is paying out more than the cash it is generating. Trailing yield: 3.4%. Lower than top quartile of British dividend payers (4.6%). Higher than average of industry peers (2.7%).Valuation Update With 7 Day Price Move • Apr 01Investor sentiment improved over the past weekAfter last week's 32% share price gain to €43.87, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 19x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 24% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €62.33 per share.Valuation Update With 7 Day Price Move • Mar 16Investor sentiment improved over the past weekAfter last week's 39% share price gain to €43.87, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 19x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 24% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €71.38 per share.Valuation Update With 7 Day Price Move • Mar 01Investor sentiment improved over the past weekAfter last week's 21% share price gain to €43.87, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 20x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 19% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €65.29 per share.Valuation Update With 7 Day Price Move • Feb 14Investor sentiment improved over the past weekAfter last week's 15% share price gain to €43.87, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 21x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 14% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €61.71 per share.Valuation Update With 7 Day Price Move • Jan 25Investor sentiment improved over the past weekAfter last week's 16% share price gain to €43.87, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 22x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 15% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €60.27 per share.Reported Earnings • Nov 03Third quarter 2021 earnings released: EPS €0.44The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: €718.0m (up 16% from 3Q 2020). Net income: €61.0m (down 3.2% from 3Q 2020). Profit margin: 8.5% (down from 10% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has increased by 2% per year.Valuation Update With 7 Day Price Move • Oct 12Investor sentiment improved over the past weekAfter last week's 15% share price gain to €43.87, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 24x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 2.4% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €61.82 per share.Reported Earnings • Aug 01Second quarter 2021 earnings releasedThe company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €714.0m (up 42% from 2Q 2020). Net income: €65.0m (up 132% from 2Q 2020). Profit margin: 9.1% (up from 5.6% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year whereas the company’s share price has fallen by 5% per year.Reported Earnings • May 04First quarter 2021 earnings releasedThe company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: €697.0m (up 13% from 1Q 2020). Net income: €71.0m (up 39% from 1Q 2020). Profit margin: 10% (up from 8.3% in 1Q 2020). The increase in margin was driven by higher revenue.Upcoming Dividend • Apr 28Upcoming dividend of €0.99 per shareEligible shareholders must have bought the stock before 05 May 2021. Payment date: 07 May 2021. Trailing yield: 2.2%. Lower than top quartile of British dividend payers (4.1%). Higher than average of industry peers (1.6%).Reported Earnings • Mar 10Full year 2020 earnings released: EPS €1.58 (vs €1.64 in FY 2019)The company reported a soft full year result with weaker earnings and revenues, although profit margins were improved. Full year 2020 results: Revenue: €2.38b (down 7.5% from FY 2019). Net income: €220.0m (down 3.5% from FY 2019). Profit margin: 9.3% (up from 8.9% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.Analyst Estimate Surprise Post Earnings • Mar 10Revenue beats expectationsRevenue exceeded analyst estimates by 0.1%. Over the next year, revenue is forecast to grow 8.6% compared to a 9.5% decline forecast for the Chemicals industry in the United Kingdom.Is New 90 Day High Low • Feb 26New 90-day low: €45.38The company is down 6.0% from its price of €48.16 on 27 November 2020. The British market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €42.92 per share.Is New 90 Day High Low • Feb 08New 90-day high: €49.44The company is up 6.0% from its price of €46.68 on 10 November 2020. The British market is also up 6.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €44.43 per share.Is New 90 Day High Low • Nov 11New 90-day high: €47.62The company is up 24% from its price of €38.30 on 13 August 2020. The British market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €39.96 per share.Analyst Estimate Surprise Post Earnings • Nov 05Revenue beats expectationsRevenue exceeded analyst estimates by 14%. Over the next year, revenue is forecast to grow 4.2% compared to a 14% decline forecast for the Chemicals industry in the United Kingdom.Is New 90 Day High Low • Oct 17New 90-day high: €45.98The company is up 20% from its price of €38.16 on 17 July 2020. The British market is down 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €40.29 per share.Is New 90 Day High Low • Sep 29New 90-day high: €42.62The company is up 19% from its price of €35.72 on 01 July 2020. The British market is down 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €39.66 per share.収支内訳Fuchs の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史LSE:0LCR 収益、費用、利益 ( )EUR Millions日付収益収益G+A経費研究開発費31 Mar 263,5733187128231 Dec 253,5633067168130 Sep 253,5592957288330 Jun 253,5652917258231 Mar 253,5723027167931 Dec 243,5253026977730 Sep 243,5092996827130 Jun 243,4832966666931 Mar 243,4822866556931 Dec 233,5412826506930 Sep 233,5682796427130 Jun 233,5942726407131 Mar 233,5402656286931 Dec 223,4122596146730 Sep 223,2842546026530 Jun 223,1002455846131 Mar 222,9822495675931 Dec 212,8712535545730 Sep 212,7672755395630 Jun 212,6692775245531 Mar 212,4592405045331 Dec 202,3782204955230 Sep 202,3601944915230 Jun 202,3961954925231 Mar 202,5452245055331 Dec 192,5722285025330 Sep 192,5662454985430 Jun 192,5522604945331 Mar 192,5672764875431 Dec 182,5672884825230 Sep 182,5642904785030 Jun 182,5372754755031 Mar 182,4982704724731 Dec 172,4732694714730 Sep 172,4262664664830 Jun 172,3782664614631 Mar 172,3352664564531 Dec 162,2672594464430 Sep 162,2432464434230 Jun 162,2072444344331 Mar 162,1362384194131 Dec 152,0792364063930 Sep 152,0022363913730 Jun 151,95423337835質の高い収益: 0LCRは 高品質の収益 を持っています。利益率の向上: 0LCRの現在の純利益率 (8.9%)は、昨年(8.5%)よりも高くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: 0LCRの収益は過去 5 年間で年間4.5%増加しました。成長の加速: 0LCRの過去 1 年間の収益成長率 ( 5.3% ) は、5 年間の平均 ( 年間4.5%を上回っています。収益対業界: 0LCRの過去 1 年間の収益成長率 ( 5.3% ) はChemicals業界-59.9%を上回りました。株主資本利益率高いROE: 0LCRの 自己資本利益率 ( 15.2% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 21:39終値2026/05/22 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Fuchs SE 10 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。28 アナリスト機関Konstantin WiechertBaader Helvea Equity ResearchVolker BosseBaader Helvea Equity ResearchAnil ShenoyBarclays25 その他のアナリストを表示
お知らせ • Jan 27+ 1 more updateFuchs SE to Report Q3, 2026 Results on Oct 30, 2026Fuchs SE announced that they will report Q3, 2026 results at 7:00 AM, Central European Standard Time on Oct 30, 2026
Reported Earnings • Nov 01Third quarter 2024 earnings releasedThird quarter 2024 results: Revenue: €902.0m (up 3.0% from 3Q 2023). Net income: €80.0m (up 3.9% from 3Q 2023). Profit margin: 8.9% (up from 8.8% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.7% p.a. on average during the next 3 years, compared to a 6.2% decline forecast for the Chemicals industry in the United Kingdom.
お知らせ • Oct 16+ 2 more updatesFuchs SE to Report Q1, 2025 Final Results on Apr 30, 2025Fuchs SE announced that they will report Q1, 2025 final results on Apr 30, 2025
お知らせ • Aug 29Fuchs SE to Report Fiscal Year 2024 Results on Mar 21, 2025Fuchs SE announced that they will report fiscal year 2024 results on Mar 21, 2025
Reported Earnings • Aug 01Second quarter 2024 earnings released: EPS: €0.59 (vs €0.50 in 2Q 2023)Second quarter 2024 results: EPS: €0.59 (up from €0.50 in 2Q 2023). Revenue: €887.0m (flat on 2Q 2023). Net income: €78.0m (up 15% from 2Q 2023). Profit margin: 8.8% (up from 7.7% in 2Q 2023). Revenue is forecast to grow 4.1% p.a. on average during the next 3 years, compared to a 5.8% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
Reported Earnings • May 01First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: €877.0m (down 6.3% from 1Q 2023). Net income: €77.0m (up 5.5% from 1Q 2023). Profit margin: 8.8% (up from 7.8% in 1Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 3.8% p.a. on average during the next 3 years, compared to a 2.7% decline forecast for the Chemicals industry in the United Kingdom.
お知らせ • Mar 26+ 1 more updateFuchs SE, Annual General Meeting, May 06, 2026Fuchs SE, Annual General Meeting, May 06, 2026, at 10:00 W. Europe Standard Time.
お知らせ • Jan 27+ 1 more updateFuchs SE to Report Q3, 2026 Results on Oct 30, 2026Fuchs SE announced that they will report Q3, 2026 results at 7:00 AM, Central European Standard Time on Oct 30, 2026
お知らせ • May 02Fuchs SE Reaffirms Earnings Guidance for the Year 2025Fuchs SE reaffirmed earnings guidance for the year 2025. For the year, the company expects sales revenues around EUR 3.7 billion and EBIT around EUR 460 million.
お知らせ • Mar 27Fuchs SE, Annual General Meeting, May 07, 2025Fuchs SE, Annual General Meeting, May 07, 2025, at 10:00 W. Europe Standard Time.
お知らせ • Mar 23Fuchs SE Proposes Dividend for the Year 2024Fuchs SE proposed to the annual general meeting a dividend increase by 5%, to EUR 1.16 (EUR 1.10) per ordinary share for the year 2024.
お知らせ • Mar 22Fuchs SE Provides Earnings Guidance for the Year 2025Fuchs SE provided earnings guidance for the year 2025. For the year, the company expects sales revenues around EUR 3.7 billion and EBIT around EUR 460 million.
Reported Earnings • Nov 01Third quarter 2024 earnings releasedThird quarter 2024 results: Revenue: €902.0m (up 3.0% from 3Q 2023). Net income: €80.0m (up 3.9% from 3Q 2023). Profit margin: 8.9% (up from 8.8% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.7% p.a. on average during the next 3 years, compared to a 6.2% decline forecast for the Chemicals industry in the United Kingdom.
お知らせ • Oct 16+ 2 more updatesFuchs SE to Report Q1, 2025 Final Results on Apr 30, 2025Fuchs SE announced that they will report Q1, 2025 final results on Apr 30, 2025
お知らせ • Sep 13Fuchs SE (XTRA:FPE3) signed a letter of intent to acquire Strub & Co. Ag.Fuchs SE (XTRA:FPE3) signed a letter of intent to acquire Strub & Co. Ag on September 13, 2024. For the period ending December 31, 2023, Strub & Co. Ag reported total revenue of €15 million. The transaction to be completed by the end of 2024.
お知らせ • Aug 29Fuchs SE to Report Fiscal Year 2024 Results on Mar 21, 2025Fuchs SE announced that they will report fiscal year 2024 results on Mar 21, 2025
Reported Earnings • Aug 01Second quarter 2024 earnings released: EPS: €0.59 (vs €0.50 in 2Q 2023)Second quarter 2024 results: EPS: €0.59 (up from €0.50 in 2Q 2023). Revenue: €887.0m (flat on 2Q 2023). Net income: €78.0m (up 15% from 2Q 2023). Profit margin: 8.8% (up from 7.7% in 2Q 2023). Revenue is forecast to grow 4.1% p.a. on average during the next 3 years, compared to a 5.8% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
Reported Earnings • May 01First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: €877.0m (down 6.3% from 1Q 2023). Net income: €77.0m (up 5.5% from 1Q 2023). Profit margin: 8.8% (up from 7.8% in 1Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 3.8% p.a. on average during the next 3 years, compared to a 2.7% decline forecast for the Chemicals industry in the United Kingdom.
お知らせ • Apr 24Fuchs SE (XTRA:FPE3) signed an agreement to acquire Lubricant Consult Gmbh (Gesellschaft FÜR Schmier- Und GrenzflÄChenaktive Stoffe).Fuchs SE (XTRA:FPE3) signed an agreement to acquire Lubricant Consult Gmbh (Gesellschaft FÜR Schmier- Und GrenzflÄChenaktive Stoffe) on April 22, 2024. As of financial year 2023, Lubricant Consult reported a sales revenue of €40 million. The transaction is subject to approval from the cartel authorities and is expected to close in the third quarter of 2024.
Reported Earnings • Mar 13Full year 2023 earnings releasedFull year 2023 results: Revenue: €3.54b (up 3.8% from FY 2022). Net income: €282.0m (up 8.9% from FY 2022). Profit margin: 8.0% (up from 7.6% in FY 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.0% p.a. on average during the next 3 years, compared to a 3.9% decline forecast for the Chemicals industry in the United Kingdom.
お知らせ • Dec 08Fuchs SE Appoints Dr. Timo Reister as Deputy Chairman of the Executive BoardThe Supervisory Board of FUCHS SE has appointed Dr. Timo Reister (44) as Deputy Chairman of the Executive Board. The appointment will take effect from January 1, 2024 and is part of the company's long-term succession planning. Timo Reister joined FUCHS in 2009 after studying business administration and completing his doctorate and has been a member of the Executive Board based in Mannheim since 2016. After joining the company, he was responsible for the OEM and specialty business in the USA as well as for FUCHS Mexico for almost five years. He then moved to China in 2014, where he headed the Asia-Pacific region as a member of the Group Management Committee. Through these stays, Timo Reister got to know FUCHS' two most important foreign markets on the ground. At present, he is responsible for the two global regions Americas and Asia-Pacific as well as for three global sales divisions: OEM, Automotive Aftermarket and Mining. The responsibilities of the Executive Board remain unchanged by this appointment. In addition to Stefan FUCHS (55) and Dr. Timo Reister (44), the at the end of 2022 newly formed Executive Board team consists of Isabelle Adelt (39), CFO, Dr. Sebastian Heiner (45), CTO, and Dr. Ralph Rheinboldt responsible for the EMEA region (Europe, Africa and Middle East) and the Industry and Specialties divisions.
Reported Earnings • Oct 28Third quarter 2023 earnings releasedThird quarter 2023 results: EPS: €0.57. Revenue: €876.0m (down 2.9% from 3Q 2022). Net income: €77.0m (up 10.0% from 3Q 2022). Profit margin: 8.8% (up from 7.8% in 3Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 5.8% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.
Buying Opportunity • Oct 26Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 6.2%. The fair value is estimated to be €43.46, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Earnings per share has grown by 8.5%. Revenue is forecast to grow by 3.6% in 2 years. Earnings is forecast to grow by 19% in the next 2 years.
お知らせ • Oct 24+ 3 more updatesFuchs SE, Annual General Meeting, May 08, 2024Fuchs SE, Annual General Meeting, May 08, 2024.
お知らせ • Sep 12Fuchs SE to Report Fiscal Year 2023 Results on Mar 12, 2024Fuchs SE announced that they will report fiscal year 2023 results Pre-Market on Mar 12, 2024
お知らせ • Sep 05Fuchs SE (XTRA:FPE3) acquired the remaining 35% stake in Fuchs lubricants SpA from Comercial Pacific Ltda..Fuchs SE (XTRA:FPE3) acquired the remaining 35% stake in Fuchs lubricants SpA from Comercial Pacific Ltda. on September 1, 2023. Fuchs SE (XTRA:FPE3) completed the acquisition of the remaining 35% stake in Fuchs lubricants SpA from Comercial Pacific Ltda. on September 1, 2023.
Reported Earnings • Jul 30Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: €886.0m (up 6.5% from 2Q 2022). Net income: €68.0m (up 12% from 2Q 2022). Profit margin: 7.7% (up from 7.3% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 2.4% p.a. on average during the next 3 years, compared to a 5.9% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
Upcoming Dividend • Apr 27Upcoming dividend of €1.07 per share at 2.9% yieldEligible shareholders must have bought the stock before 04 May 2023. Payment date: 08 May 2023. Payout ratio is a comfortable 57% but the company is paying out more than the cash it is generating. Trailing yield: 2.9%. Lower than top quartile of British dividend payers (5.8%). Higher than average of industry peers (2.3%).
Reported Earnings • Mar 09Full year 2022 earnings released: EPS: €1.87 (vs €1.82 in FY 2021)Full year 2022 results: EPS: €1.87 (up from €1.82 in FY 2021). Revenue: €3.41b (up 19% from FY 2021). Net income: €259.0m (up 2.4% from FY 2021). Profit margin: 7.6% (down from 8.8% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.6% p.a. on average during the next 3 years, compared to a 1.5% growth forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 8% per year and the company’s share price has also increased by 8% per year.
お知らせ • Jan 02+ 3 more updatesFuchs Petrolub SE, Annual General Meeting, May 03, 2023Fuchs Petrolub SE, Annual General Meeting, May 03, 2023.
Reported Earnings • Oct 30Third quarter 2022 earnings releasedThird quarter 2022 results: Revenue: €902.0m (up 26% from 3Q 2021). Net income: €70.0m (up 15% from 3Q 2021). Profit margin: 7.8% (down from 8.5% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 8.6% decline forecast for the Chemicals industry in the United Kingdom.
お知らせ • Oct 25Fuchs Petrolub SE to Report Fiscal Year 2022 Results on Mar 08, 2023Fuchs Petrolub SE announced that they will report fiscal year 2022 results on Mar 08, 2023
Valuation Update With 7 Day Price Move • Sep 29Investor sentiment improved over the past weekAfter last week's 65% share price gain to €43.87, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 17x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 44% over the past three years.
Valuation Update With 7 Day Price Move • Sep 14Investor sentiment improved over the past weekAfter last week's 60% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 18x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 36% over the past three years.
Valuation Update With 7 Day Price Move • Aug 30Investor sentiment improved over the past weekAfter last week's 59% share price gain to €43.87, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 18x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 50% over the past three years.
Valuation Update With 7 Day Price Move • Aug 15Investor sentiment improved over the past weekAfter last week's 54% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 19x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 49% over the past three years.
Reported Earnings • Aug 01Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: €832.0m (up 17% from 2Q 2021). Net income: €61.0m (down 6.2% from 2Q 2021). Profit margin: 7.3% (down from 9.1% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 4.7% compared to a 20% decline forecast for the industry in the United Kingdom.
Valuation Update With 7 Day Price Move • Jul 27Investor sentiment improved over the past weekAfter last week's 52% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 19x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 35% over the past three years.
Valuation Update With 7 Day Price Move • Jul 12Investor sentiment improved over the past weekAfter last week's 63% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 19x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 31% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €80.44 per share.
Valuation Update With 7 Day Price Move • Jun 27Investor sentiment improved over the past weekAfter last week's 75% share price gain to €43.87, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 17x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 32% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €84.69 per share.
Valuation Update With 7 Day Price Move • Jun 10Investor sentiment improved over the past weekAfter last week's 50% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 17x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 36% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €74.01 per share.
Valuation Update With 7 Day Price Move • May 26Investor sentiment improved over the past weekAfter last week's 59% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 18x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 34% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €77.33 per share.
Valuation Update With 7 Day Price Move • May 06Investor sentiment improved over the past weekAfter last week's 46% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 20x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 33% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €77.38 per share.
Reported Earnings • May 01First quarter 2022 earnings releasedFirst quarter 2022 results: Revenue: €808.0m (up 16% from 1Q 2021). Net income: €67.0m (down 5.6% from 1Q 2021). Profit margin: 8.3% (down from 10% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 6.9% compared to a 16% decline forecast for the industry in the United Kingdom.
Upcoming Dividend • Apr 27Upcoming dividend of €1.03 per shareEligible shareholders must have bought the stock before 04 May 2022. Payment date: 06 May 2022. Payout ratio is a comfortable 57% but the company is paying out more than the cash it is generating. Trailing yield: 3.4%. Lower than top quartile of British dividend payers (4.6%). Higher than average of industry peers (2.7%).
Valuation Update With 7 Day Price Move • Apr 01Investor sentiment improved over the past weekAfter last week's 32% share price gain to €43.87, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 19x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 24% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €62.33 per share.
Valuation Update With 7 Day Price Move • Mar 16Investor sentiment improved over the past weekAfter last week's 39% share price gain to €43.87, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 19x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 24% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €71.38 per share.
Valuation Update With 7 Day Price Move • Mar 01Investor sentiment improved over the past weekAfter last week's 21% share price gain to €43.87, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 20x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 19% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €65.29 per share.
Valuation Update With 7 Day Price Move • Feb 14Investor sentiment improved over the past weekAfter last week's 15% share price gain to €43.87, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 21x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 14% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €61.71 per share.
Valuation Update With 7 Day Price Move • Jan 25Investor sentiment improved over the past weekAfter last week's 16% share price gain to €43.87, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 22x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 15% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €60.27 per share.
Reported Earnings • Nov 03Third quarter 2021 earnings released: EPS €0.44The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: €718.0m (up 16% from 3Q 2020). Net income: €61.0m (down 3.2% from 3Q 2020). Profit margin: 8.5% (down from 10% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has increased by 2% per year.
Valuation Update With 7 Day Price Move • Oct 12Investor sentiment improved over the past weekAfter last week's 15% share price gain to €43.87, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 24x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 2.4% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €61.82 per share.
Reported Earnings • Aug 01Second quarter 2021 earnings releasedThe company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €714.0m (up 42% from 2Q 2020). Net income: €65.0m (up 132% from 2Q 2020). Profit margin: 9.1% (up from 5.6% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year whereas the company’s share price has fallen by 5% per year.
Reported Earnings • May 04First quarter 2021 earnings releasedThe company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: €697.0m (up 13% from 1Q 2020). Net income: €71.0m (up 39% from 1Q 2020). Profit margin: 10% (up from 8.3% in 1Q 2020). The increase in margin was driven by higher revenue.
Upcoming Dividend • Apr 28Upcoming dividend of €0.99 per shareEligible shareholders must have bought the stock before 05 May 2021. Payment date: 07 May 2021. Trailing yield: 2.2%. Lower than top quartile of British dividend payers (4.1%). Higher than average of industry peers (1.6%).
Reported Earnings • Mar 10Full year 2020 earnings released: EPS €1.58 (vs €1.64 in FY 2019)The company reported a soft full year result with weaker earnings and revenues, although profit margins were improved. Full year 2020 results: Revenue: €2.38b (down 7.5% from FY 2019). Net income: €220.0m (down 3.5% from FY 2019). Profit margin: 9.3% (up from 8.9% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.
Analyst Estimate Surprise Post Earnings • Mar 10Revenue beats expectationsRevenue exceeded analyst estimates by 0.1%. Over the next year, revenue is forecast to grow 8.6% compared to a 9.5% decline forecast for the Chemicals industry in the United Kingdom.
Is New 90 Day High Low • Feb 26New 90-day low: €45.38The company is down 6.0% from its price of €48.16 on 27 November 2020. The British market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €42.92 per share.
Is New 90 Day High Low • Feb 08New 90-day high: €49.44The company is up 6.0% from its price of €46.68 on 10 November 2020. The British market is also up 6.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €44.43 per share.
Is New 90 Day High Low • Nov 11New 90-day high: €47.62The company is up 24% from its price of €38.30 on 13 August 2020. The British market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €39.96 per share.
Analyst Estimate Surprise Post Earnings • Nov 05Revenue beats expectationsRevenue exceeded analyst estimates by 14%. Over the next year, revenue is forecast to grow 4.2% compared to a 14% decline forecast for the Chemicals industry in the United Kingdom.
Is New 90 Day High Low • Oct 17New 90-day high: €45.98The company is up 20% from its price of €38.16 on 17 July 2020. The British market is down 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €40.29 per share.
Is New 90 Day High Low • Sep 29New 90-day high: €42.62The company is up 19% from its price of €35.72 on 01 July 2020. The British market is down 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €39.66 per share.